Why Is Autolus Therapeutics Stock Trading Higher On Tuesday? - Autolus Therapeutics (NASDAQ:AUTL)

Why Is Autolus Therapeutics Stock Trading Higher On Tuesday? - Autolus Therapeutics (NASDAQ:AUTL)

The U.K.’s National Institute for Health and Care Excellence (NICE) published on Tuesday draft guidance recommending Autolus Therapeutics plc’s (NASDAQ:AUTL) Aucatzyl (obecabtagene autoleucel, or obe-cel) for use in the National Health Service (NHS) for adult patients (≥26 years) with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (r/r B-ALL). • AUTL stock is showing exceptional strength. Get the market research here. Acute…

FDA OKs Sarepta study of new immune suppression approach with Elevidys; Gilead buys preclinical TREX1 program

Plus, news about Nuvalent and Phrontline: 🟢 FDA clears Sarepta’s next step: Sarepta said it will study its Duchenne muscular dystrophy gene therapy Elevidys with a new ...